About Us

Mission

The Biologic Association's mission to foster and convene a collaboration for shared and coordinated efforts to speak with a unified voice in the musculoskeletal biologics environment, advocating for the responsible use of biologics in clinical practice, spearheading standards development, and assessing and reporting on the safety and efficacy of biologic interventions.

The Biologic Association Website

The purpose of Biologic Association’s site is to create a medical education community that fosters collaboration and offers a pool of expert clinical references for access by all members. This site is being established to address the needs of physicians so that there is a single destination site to provide educational material on an on-going basis as the underlying science evolves.

Our goal is global. The Biologic Association provides educational assistance worldwide for physicians and healthcare professionals. Our platform allows our members to deepen their clinical knowledge, gain insight into medical options, and stay current on medical and scientific research and findings, patient care and the treatments.

The Biologic Association website will provide educational access across a variety of platforms:

Best Available Evidence

This section will provide the most up to date scientifically supported information on the safety and efficacy of biologic interventions.

"Best Practice" Technique Videos.

Best practices videos: Adipose harvest, PRP, BMAC (posterior and Iliac crest)

Consensus Statements.

Access to peer reviewed material focusing on musculoskeletal biologics. This will include information presented in abstract form with additional access being planned.

What's New

Breakthrough technologies and clinical solutions will be covered. While still lacking comprehensive clinical support this area is intended to bring to the forefront leading edge practices that might evolve into new standards of care.

CME Resources

CME will be developed and provided in the future based on scientifically supported information. Stay tuned. 

Biologic Association Website Policy

The Biologics Association will host an independent website platform that is entirely separate from any of the participating Organizations’ website platforms. This website will be a central hub to post Association business, proceedings and activities and will also be a trusted source for physicians to attain vetted and graded educational material, current best practices and procedures. In order to minimize the potential bias of industry, and physician relationships with industry, there will be NO company logos, advertising or references posted on the Biologics Association educational website at any time. Industry participation will be in a separate, bifurcated area of the site. Additionally, all members of the website oversite committee (WOC) will be subject to a rigorous Conflict of Interest review by the Board of Directors before becoming an official voting member of the WOC.

Website Oversight Committee

The website oversight committee (WOC) will be composed of one of the three official delegates from each of the Regular Member Organizations, a committee chairman, a Medsite representative (to provide a business and site management perspective), and additional working members. The committee will always have an odd number of members, but must have at least 5 members. Voting for website content will follow the protocol established in the bylaws, however voting can be accomplished within the committee and does not have to have a formal Association Board vote. The WOC will be responsible for grading and vetting all data, scientific and procedural material that is posted on the website, along with vetting all corporate advertising for minimum criteria for the separate corporate area of the website.

Voting

All material posted on the website must have unanimous agreement of the voting Regular Member Organization WOC delegates and achieve a majority vote of all committee members before any content is posted. All web content will be vetted by the following procedure before voting can commence.

Scientific Content Review Process for Main Biologics Alliance website content posting

All educational content will be reviewed by the WOC for minimum criteria prior to posting.

Minimum content requirements (must have at least one of the following requirements):
• Content has already been presented at one of the Biologics Association Member Organization’s national meeting. Content will be considered as peer reviewed.
• Content that has already been published in a PubMed indexed, peer-reviewed journal.
• There are no identified ethical or regulatory concerns of the described technique, device application, or biologic.
• There is no identified conflict of interest by the presenter, Biologics Association or the WOC.
A minimum of three (3) WOC members will review each piece of educational content for the minimum criteria, and will then preliminarily vote to allow or reject the media. If accepted, the material will then undergo a formal vote by the WOC before posting on the website.

Website Oversight committee

• David Flanigan, MD (Chair)
• Rick Kovach (Medsite, LLC)
• Jack Farr, MD (Lead, Corporate site)
• Adam Anz, MD (Lead, Educational site)
• Seth Sherman, MD
• Adam Yanke, MD
• Voting members from AOSSM, AANA, ICRS, ON
• Scott Rodeo, MD (AOSSM)
• Brian Cole, MD, MBA (AANA)
• Christian Lattermann, MD (ICRS)

Biologics Association Conflict of Interest Policy
Adopted February 6, 2020

1. Conflict of Interest Disclosure

In order to promote transparency and confidence in the educational programs and in the decisions of the Biologics Association (BA), the Board of Directors has adopted this mandatory disclosure policy. BA Members must be as free of outside influence as is reasonable and any potentially conflicting interests or commercial relationships must be disclosed. Each participant in any BA educational program, author of enduring materials, or BA subcommittee workgroup must disclose all industry activities and/or relationships. At each BA meeting, Members of the group will be reminded that full disclosure must be made of any potential conflict of interest (COI) when a matter involving that interest is discussed.

2. Method of Disclosure

All voting and non-voting members of the BA have the obligation to disclose all potential conflicts of interests in writing, using a form approved by the BA Board of Directors, and on the BA website. Members are responsible for the accuracy and completeness of their information. In addition, BA Members have an obligation to review and update their personal information at least semiannually, in January and July.

3. Consequences for Failing to Disclose

The failure of any BA Member to make a thorough and complete disclosure will result in the participant being asked not to participate in BA voting, writing of enduring materials or participation in official BA business or committee work.

4. Resolving Relevant Conflict of Interest

All Members participating in the production and authoring of any enduring materials will not be allowed to participate if a relevant COI to that work exists. The Member will be given the opportunity to resolve the COI, and will only be allowed to participate after being authorized to resume activity by Board of Directors vote.

All Members participating in the evaluation of written documents, video presentations or other educational materials for the BA website will not be allowed to participate if a relevant COI to that work exists. The Member will be given the opportunity to resolve the COI, and will only be allowed to participate after being authorized to resume activity by Board of Directors vote.

5. Resolving Conflict of Interest in Research

Reimbursement for reasonable administrative costs in conducting or participating in a scientifically sound research clinical trial is acceptable. A BA Member shall make his or her best efforts to ensure, at the completion of the study, that relevant research results are reported and reported truthfully and honestly with no bias or influence from funding sources, regardless of positive or negative findings.

6. Avoiding Conflict of Interest in Educational meetings

A BA Member, when attending an industry-sponsored non-CME educational
event, shall accept only reasonable honoraria, tuition, travel and modest hospitality, including meals and receptions. Bona fide faculty members at a CME event may accept industry-support for travel expenses, lodging and meals.

7. Avoidance in Conflict of Interest with Industry

BA Members shall decline subsidies or other financial support from industry, unless involved directly with research, consulting or product development including royalties.
If a BA member has influence in selecting a particular product or service for an entity, they shall disclose any relationship with industry per this COI policy and will abstain from the decision making process for that particular product or service.